at
Knowledge4COVID-19
https://research.tib.eu/covid-19/entity/33792920
Property
Value
is
?:
annotates
of
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0003916
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0004374
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0004738
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0009617
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0021420
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0022750
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0022756
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0029140
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0040225
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0086418
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0086460
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0162648
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0206034
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0206035
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0282440
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0871582
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C0872152
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C1328956
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C1615608
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C2718080
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C4505337
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C5200696
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C5200697
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C5203670
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C5203676
>
<
https://research.tib.eu/covid-19/entity/33792920_HAS_TOPIC_C5392141
>
?:
authorAffiliation
[\'Pfizer Inc, New York, New York, USA.\', \'Consilium Salmonson and Hemmings, London, UK.\']
?:
citedBy
-1
?:
creator
<
https://research.tib.eu/covid-19/entity/Alemayehu_Demissie
>
<
https://research.tib.eu/covid-19/entity/Hemmings_Robert
>
<
https://research.tib.eu/covid-19/entity/Natarajan_Kannan
>
<
https://research.tib.eu/covid-19/entity/Roychoudhury_Satrajit
>
?:
doi
10.1002/cpt.2248
?:
doi
<
https://research.tib.eu/covid-19/entity/10.1002/cpt.2248
>
?:
hasPublicationType
<
https://research.tib.eu/covid-19/entity/Journal_Article
>
<
https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t
>
<
https://research.tib.eu/covid-19/entity/Review
>
?:
journal
Clinical pharmacology and therapeutics
is
?:
pmid
of
<
https://research.tib.eu/covid-19/entity/33792920
>
?:
pmid
<
https://research.tib.eu/covid-19/entity/33792920
>
?:
pmid
33792920
?:
publication_isRelatedTo_Disease
<
https://research.tib.eu/covid-19/entity/Covid-19
>
?:
rankingScore_SJR
1.699
?:
rankingScore_hIndex
169
?:
title
Perspectives on Virtual (Remote) Clinical Trials as the \'New Normal\' to Accelerate Drug Development.
?:
type
<
https://research.tib.eu/covid-19/vocab/Publication
>
<
https://research.tib.eu/covid-19/vocab/Publication_Author
>
?:
year
2022
Metadata
Anon_0
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataItem
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://www.w3.org/2004/03/trix/rdfg-1/Graph
>
<
http://xmlns.com/foaf/0.1/primaryTopic
>
<
https://research.tib.eu/covid-19/entity/33792920
>
<
http://xmlns.com/foaf/0.1/topic
>
Anon_0
<
http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes
>
<
https://research.tib.eu/covid-19/data/entity/33792920
>
<
http://purl.org/net/provenance/ns#createdBy
>
Anon_1
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataCreation
>
<
http://purl.org/net/provenance/ns#performedAt
>
2025-01-23T21:22:59.516Z
<
http://purl.org/net/provenance/ns#performedBy
>
Anon_2
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataProvidingService
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#deployedSoftware
>
Anon_3
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://usefulinc.com/ns/doap#Version
>
<
http://usefulinc.com/ns/doap#revision
>
0.4
<
http://www.w3.org/2000/01/rdf-schema#seeAlso
>
<
https://research.tib.eu/covid-19/
>
<
http://purl.org/net/provenance/ns#usedData
>
Anon_4
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataItem
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#QueryResult
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://www.w3.org/2004/03/trix/rdfg-1/Graph
>
<
http://purl.org/net/provenance/ns#retrievedBy
>
Anon_5
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataAccess
>
<
http://purl.org/net/provenance/ns#performedAt
>
2025-01-23T21:22:59.516Z
<
http://purl.org/net/provenance/ns#performedBy
>
Anon_2
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataProvidingService
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#deployedSoftware
>
Anon_3
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://usefulinc.com/ns/doap#Version
>
<
http://usefulinc.com/ns/doap#revision
>
0.4
<
http://www.w3.org/2000/01/rdf-schema#seeAlso
>
<
https://research.tib.eu/covid-19/
>
<
http://purl.org/net/provenance/ns#accessedService
>
<
https://labs.tib.eu/sdm/covid19kg/sparql
>
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#createdBy
>
Anon_6
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#DataCreation
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#QueryExecution
>
<
http://purl.org/net/provenance/ns#performedBy
>
<
https://labs.tib.eu/sdm/covid19kg/sparql
>
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/ns#Actor
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#DataCreatingService
>
<
http://purl.org/net/provenance/ns#usedGuideline
>
Anon_7
(
more
)
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://purl.org/net/provenance/types#SPARQLQuery
>
<
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
>
<
http://spinrdf.org/sp#Describe
>
<
http://www.w3.org/2000/01/rdf-schema#label
>
DESCRIBE <http://research.tib.eu/covid-19/entity/33792920>
expand all
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}